A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment
Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The main goal of this study is to evaluate the safety and tolerability of 40 or 80 mg
atomoxetine as a treatment for cocaine dependence. The Phase I studies summarized above
support the safety of atomoxetine in combination with stimulants. As the next step, the
investigators will evaluate the safety and tolerability of atomoxetine in a small clinical
trial with cocaine users. If atomoxetine is found to be promising in this study and
sufficiently powered, double-blind, placebo-controlled studies will be proposed.